These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 34643766)

  • 1. Assessment of immune status of laryngeal squamous cell carcinoma can predict prognosis and guide treatment.
    Wang X; Cao K; Guo E; Mao X; An C; Guo L; Zhang C; Guo J; Yang X; Sun J; Yang W; Li X; Miao S
    Cancer Immunol Immunother; 2022 May; 71(5):1199-1220. PubMed ID: 34643766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unlocking the potential of HHLA2: identifying functional immune infiltrating cells in the tumor microenvironment and predicting clinical outcomes in laryngeal squamous cell carcinoma.
    Li W; You J; Xue H; Liu Y; Chen J; Zheng X; Chen L; Wu C
    Cancer Immunol Immunother; 2024 Aug; 73(10):207. PubMed ID: 39105870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. APE1 facilitates PD-L1-mediated progression of laryngeal and hypopharyngeal squamous cell carcinoma.
    Wang J; Lun L; Jiang X; Wang Y; Li X; Du G; Wang J
    Int Immunopharmacol; 2021 Aug; 97():107675. PubMed ID: 33964809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of systemic inflammatory response index (SIRI) and tumor-infiltrating lymphocytes (TILs) in the prognosis of patients with laryngeal squamous cell carcinoma.
    Wang T; Zhang D; Tang D; Heng Y; Lu LM; Tao L
    J Cancer Res Clin Oncol; 2023 Aug; 149(9):5627-5636. PubMed ID: 36520215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction and validation of immune-related LncRNAs classifier to predict prognosis and immunotherapy response in laryngeal squamous cell carcinoma.
    Wang X; Pan Y; Ou Y; Duan T; Zou Y; Zhou X
    World J Surg Oncol; 2022 May; 20(1):164. PubMed ID: 35606755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of CD103
    Smith JD; Bellile EL; Ellsperman SE; Heft-Neal ME; Mann JE; Birkeland AC; Hoesli RC; Swiecicki PL; Worden FP; Schonewolf C; Shah JL; Mierzwa ML; Rosko AJ; Stucken CL; Chinn SB; Shuman AG; Casper KA; Malloy KM; Prince MEP; Wolf GT; Thomas DG; McHugh JB; Chad Brenner J; Spector ME
    Oral Oncol; 2022 Dec; 135():106226. PubMed ID: 36323071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor Infiltrating Lymphocytes and CD8+ T Cell Subsets as Prognostic Markers in Patients with Surgically Treated Laryngeal Squamous Cell Carcinoma.
    Chatzopoulos K; Kotoula V; Manoussou K; Markou K; Vlachtsis K; Angouridakis N; Nikolaou A; Vassilakopoulou M; Psyrri A; Fountzilas G
    Head Neck Pathol; 2020 Sep; 14(3):689-700. PubMed ID: 31749124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An immune-related lncRNA pairs signature to identify the prognosis and predict the immune landscape of laryngeal squamous cell carcinoma.
    Qian L; Ni T; Fei B; Sun H; Ni H
    BMC Cancer; 2022 May; 22(1):545. PubMed ID: 35568824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor necrosis factor superfamily member 13 is a novel biomarker for diagnosis and prognosis and promotes cancer cell proliferation in laryngeal squamous cell carcinoma.
    Wang R; Guo Y; Ma H; Feng L; Wang Q; Chen X; Lian M; Wang H; Fang J
    Tumour Biol; 2016 Feb; 37(2):2635-45. PubMed ID: 26395262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triosephosphate isomerase 1 may be a risk predictor in laryngeal squamous cell carcinoma: a multi-centered study integrating bulk RNA, single-cell RNA, and protein immunohistochemistry.
    Li JD; Chen Y; Jing SW; Wang LT; Zhou YH; Liu ZS; Song C; Li DZ; Wang HQ; Huang ZG; Dang YW; Chen G; Luo JY
    Eur J Med Res; 2023 Dec; 28(1):591. PubMed ID: 38102653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The analysis of tumor-infiltrating immune cell and ceRNA networks in laryngeal squamous cell carcinoma.
    Li D; Dong K; Su J; Xue H; Tian J; Wu Y; Wang J
    Medicine (Baltimore); 2022 Aug; 101(31):e29555. PubMed ID: 35945754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of tumor-infiltrating CD103 resident memory T-cell content in recurrent laryngeal squamous cell carcinoma.
    Mann JE; Smith JD; Birkeland AC; Bellile E; Swiecicki P; Mierzwa M; Chinn SB; Shuman AG; Malloy KM; Casper KA; McLean SA; Moyer JS; Wolf GT; Bradford CR; Prince ME; Carey TE; McHugh JB; Spector ME; Brenner JC
    Cancer Immunol Immunother; 2019 Feb; 68(2):213-220. PubMed ID: 30361882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic impact of neutrophils-to-lymphocytes ratio (NLR), PD-L1 expression, and tumor immune microenvironment in laryngeal cancer.
    Franz L; Alessandrini L; Fasanaro E; Gaudioso P; Carli A; Nicolai P; Marioni G
    Ann Diagn Pathol; 2021 Feb; 50():151657. PubMed ID: 33189034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SLC7A11, a component of cysteine/glutamate transporter, is a novel biomarker for the diagnosis and prognosis in laryngeal squamous cell carcinoma.
    Ma Z; Zhang H; Lian M; Yue C; Dong G; Jin Y; Li R; Wan H; Wang R; Wang Y; Zhai J; Ma H; Feng L; Han J; Liu S; Guo Y; Li J; Liu Y; Fang J; Liu H
    Oncol Rep; 2017 Nov; 38(5):3019-3029. PubMed ID: 29048627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-Infiltrating Lymphocytes in Patients With Advanced Laryngeal Cancer Undergoing Bioselection.
    Heft Neal ME; Smith JD; Birkeland AC; Haring CT; Chinn SB; Shuman AG; Casper KA; Malloy KM; Stucken CL; Mclean SA; Rosko AJ; Mierzwa ML; Shah J; Schonewolf C; Swiecicki PL; Worden FP; Wolf GT; Bradford CR; Prince MEP; Brenner JC; Spector ME
    Otolaryngol Head Neck Surg; 2022 Mar; 166(3):498-505. PubMed ID: 34030495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD206
    Heng Y; Zhu X; Lin H; Jingyu M; Ding X; Tao L; Lu L
    J Transl Med; 2023 Mar; 21(1):167. PubMed ID: 36864443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic nomogram based on immune scores for laryngeal squamous cell cancer.
    Liao L; Chen W; Lai H; Yi X; Wang D
    Eur Arch Otorhinolaryngol; 2021 Jan; 278(1):141-148. PubMed ID: 32638085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LMX1B mRNA expression and its gene body CpG methylation are valuable prognostic biomarkers for laryngeal squamous cell carcinoma.
    Fan L; Zhang A; Deng P
    Biomed Pharmacother; 2019 Sep; 117():109174. PubMed ID: 31387183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of zinc finger protein 71 in laryngeal squamous cell carcinoma tissues and its potential molecular mechanism and clinical significance: a study based on immunohistochemistry staining and data mining.
    Jiang FC; Luo JY; Dang YW; Lu HP; Li DM; Huang ZG; Tang YL; Fang YY; Tang YX; Su YS; Dai WB; Pan SL; Feng ZB; Chen G; He J
    World J Surg Oncol; 2022 Nov; 20(1):359. PubMed ID: 36369089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low body mass index is associated with reduced intratumoral CD4
    Murad LD; Silva TQ; Schilithz AOC; Fernandes PV; Monteiro M; Murad LB; Fialho E
    Nutr Res; 2022 Jun; 102():1-12. PubMed ID: 35366454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.